Daiwa Securities Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-36
| Closed | – | – | 1355 |
|
|
2023
Q3 | $0 | Hold |
36
| – | – | ﹤0.01% | 1315 |
|
|
2023
Q2 | $0 | Hold |
36
| – | – | ﹤0.01% | 1328 |
|
|
2023
Q1 | $0 | Hold |
36
| – | – | ﹤0.01% | 1302 |
|
|
2022
Q4 | $1K | Hold |
36
| – | – | ﹤0.01% | 1273 |
|
|
2022
Q3 | $2K | Hold |
36
| – | – | ﹤0.01% | 1231 |
|
|
2022
Q2 | $2K | Hold |
36
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q1 | $3K | Hold |
36
| – | – | ﹤0.01% | 1215 |
|
|
2021
Q4 | $7K | Sell |
36
-6
| -14% | -$1.17K | ﹤0.01% | 1164 |
|
|
2021
Q3 | $11K | Buy |
42
+18
| +75% | +$4.71K | ﹤0.01% | 1125 |
|
|
2021
Q2 | $6K | Hold |
24
| – | – | ﹤0.01% | 1059 |
|
|
2021
Q1 | $7K | Buy |
24
+2
| +9% | +$583 | ﹤0.01% | 1058 |
|
|
2020
Q4 | $6K | Sell |
22
-44
| -67% | -$12K | ﹤0.01% | 1046 |
|
|
2020
Q3 | $16K | Hold |
66
| – | – | ﹤0.01% | 1001 |
|
|
2020
Q2 | $18K | Hold |
66
| – | – | ﹤0.01% | 1017 |
|
|
2020
Q1 | $18K | Hold |
66
| – | – | ﹤0.01% | 1006 |
|
|
2019
Q4 | $21K | Sell |
66
-455
| -87% | -$145K | ﹤0.01% | 1001 |
|
|
2019
Q3 | $142K | Buy |
521
+36
| +7% | +$9.81K | ﹤0.01% | 904 |
|
|
2019
Q2 | $259K | Sell |
485
-1
| -0.2% | -$534 | ﹤0.01% | 826 |
|
|
2019
Q1 | $245K | Hold |
486
| – | – | ﹤0.01% | 824 |
|
|
2018
Q4 | $240K | Buy |
486
+16
| +3% | +$7.9K | ﹤0.01% | 785 |
|
|
2018
Q3 | $429K | Buy |
470
+34
| +8% | +$31K | ﹤0.01% | 692 |
|
|
2018
Q2 | $320K | Buy |
436
+366
| +523% | +$269K | ﹤0.01% | 772 |
|
|
2018
Q1 | $111K | Buy |
+70
| New | +$111K | ﹤0.01% | 897 |
|